
EU commissioner Margrethe Vestager has agreed to temporarily relax state aid rules that the tech industry argued were holding up several countries’ support for start-ups, reported the Financial Times.
Many venture-backed technology companies are classified as being in “financial difficulty” under EU rules because they are run at a loss to accelerate growth or have sold a large portion of the company to investors.
As a result, under state aid rules designed to prevent countries from propping up failing national companies, many European start-ups are unable to benefit from the kind of state support that has been made widely available to more traditional businesses in recent months.
The EU is now moving to extend the “temporary framework” introduced in March to relax state aid rules for struggling companies, so that it includes innovative start-ups and other “micro and small companies”.
Ms Vestager, the EU’s executive vice-president who leads competition policy, said such businesses were “crucial for the economic recovery of the Union”. Private investors would also be able to invest alongside government funds under the new proposals, she added.
Full Content: Financial Times
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Meta Begins Defense After FTC Concludes Case in Landmark Antitrust Trial
May 15, 2025 by
CPI
UK Data Bill Still No Closer to Passage As Parliamentary ‘Ping-Pong’ Drags On
May 15, 2025 by
CPI
Regeneron Pharmaceuticals Awarded $271.2M in Damages Against Amgen
May 15, 2025 by
CPI
FTC Chair Proposes 15% Staff Reduction Amid Budget Constraints
May 15, 2025 by
CPI
UK Urges Antitrust Watchdog to Prioritize Growth and Clarity in Business Regulation
May 15, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas